Scarica l'app Stockscreener
17.75
1.43%
0.25
Precedente Chiudi:
$17.50
Aprire:
$17.41
Volume 24 ore:
21,736
Relative Volume:
0.31
Capitalizzazione di mercato:
$N/A
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+2.72%
1M Prestazione:
+9.43%
6M Prestazione:
-33.09%
1 anno Prestazione:
-36.18%
Intervallo 1D:
$17.41
$17.89
Intervallo di 1 settimana:
$16.85
$18.39
Portata 52W:
$13.42
$31.65
Virtus Lifesci Biotech Clinical Trials Etf Stock (BBC) Company Profile
Nome
Virtus Lifesci Biotech Clinical Trials Etf
Settore
Industria
Telefono
-
Indirizzo
-
Confronta BBC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BBC
Virtus Lifesci Biotech Clinical Trials Etf
|
17.75 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
292.58 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
594.20 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
597.04 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
234.74 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
521.51 | 124.43B | 0 | 0 | 0 | 0.00 |
Virtus Lifesci Biotech Clinical Trials Etf Borsa (BBC) Ultime notizie
Learn to Evaluate (BBC) using the Charts - news.stocktradersdaily.com
Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation - Benzinga
ETFs Last Week: Funds Lead The Charge As Markets Stage A Return To Risk-On - Benzinga
Tech Rally Boosted Wall Street Last Week: Winning ETFs in Focus - TradingView
6 Best-Performing ETFs of Last Week - TradingView
(BBC) Investment Analysis and Advice - news.stocktradersdaily.com
Wall Street Week Ahead - Seeking Alpha
(BBC) Technical Data - news.stocktradersdaily.com
Trend Tracker for (BBC) - news.stocktradersdaily.com
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
(BBC) Trading Signals - Stock Traders Daily
(BBC) Trading Advice - Stock Traders Daily
(BBC) Proactive Strategies - Stock Traders Daily
Stock Market Movers Today • Top Gainers & Losers - Benzinga
When (BBC) Moves Investors should Listen - Stock Traders Daily
(BBC) Long Term Investment Analysis - Stock Traders Daily
How to Take Advantage of moves in (BBC) - Stock Traders Daily
(BBC) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Capitulation in biotech is near, as well as a rally – Piper Sandler (NYSEARCA:XBI) - Seeking Alpha
The Great Rotation: Just Getting Started? - ETF Trends
5 Top ETFs of Last Week - Nasdaq
SBIO, XBI, or BBP: Which is the Best Biotech ETF, According to Analysts? - TipRanks
9 Best Biotech ETFs for 2024 - MSN
The 5 Best Biotech ETFs of 2024 - ETF.com
5 Best ETF Areas of Last Week - Nasdaq
This biotech ETF sees ‘breakout’ while U.S. small-cap technology stocks lag - MarketWatch
Top and Flop Industry ETFs of Q3 - Nasdaq
ETFs to Play Biden's 2024 Reelection Campaign Launch - Nasdaq
ALPS’ Biotech ETF SBIO Week’s Top Performer - Nasdaq
Innovation Reigns In 10 Best-Performing ETFs Of The Last 3 Months - Financial Advisor (Mag)
Biotech ETFs Advance on Speculation of a Takeover Bid for Global Blood Therapeutics - ETF Trends
5 ETFs Riding High on the Biotech Comeback - Yahoo Finance
Biotech ETFs Are Making a Comeback - ETF Trends
Best Performing ETFs For June 2022 - TheStreet
Biotech ETF Tops in June: 5 Stocks That Outperform - Yahoo Finance
Betting on Biotech Bear Market Expiration Date - ETF Trends
Best & Worst Performing ETFs Of 2022 - Yahoo Finance
Positioning for Biotech Bounceback - ETF Trends
Biotech ETFs That Outperformed Last Week - Yahoo Finance
ETF Exchange: Latest ETF News & Insights | Pensions & Investments - Pensions & Investments
Biotech Ready to Participate in Healthcare Bullishness - Nasdaq
Drug Price Debate Might Not Hinder Biotech ETFs - ETFdb.com
Size Up SBIO Ahead of Biotech Rebound - ETF Trends
Finding Synergy With SPY - etf.com
Healthcare ETFs Surge on FDA Full-Vaccine Nod & Deal News - Zacks Investment Research
Biotech ETFs Surge on Biogen's Alzheimer Drug Approval - Yahoo Finance
After AstraZeneca, Oxford Nanopore Might Be The Next UK COVID Winner - Investing.com
Want to Use ETFs to Play Biotech? Choose Wisely. - Barron's
Unless Sorrento Makes Solid Progress Soon, It Will Likely Go Below $5 - Nasdaq
A Healthcare ETF Review: Biotech Beckons under Biden - ETF Trends
Medical Breakthrough ETFs for More than Just COVID - ETF Database
Virtus Lifesci Biotech Clinical Trials Etf Azioni (BBC) Dati Finanziari
Non sono disponibili dati finanziari per Virtus Lifesci Biotech Clinical Trials Etf (BBC). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.97%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):